COO Ivan Mishanin Shares His Vision for Brainify.AI with Tech Times

In a recent interview with Noah Miller at Tech Times, our COO & Co-Founder, Ivan Mishanin, opened up about his entrepreneurial journey and his vision for our company, Brainify.AI. Ivan shared his personal experiences, including overcoming depression, which led him to understand the critical need for a more objective approach to mental health.

From this personal revelation, Ivan has channeled his entrepreneurial skills into building Brainify.AI with a mission to transform drug development and in-clinic diagnostics. The company aims to accurately forecast treatment responses, aspiring to significantly impact over a billion individuals affected by psychiatric disorders worldwide.

To achieve this lofty goal, Brainify.AI is collaborating with distinguished institutions such as Harvard Medical School, Cornell University, Massachusetts General Hospital, and Northwell Health. The company's innovative approach was recently recognized, making them a finalist of the Harvard Presidents' Innovation Challenge 2023 organized by Harvard Innovation Labs.